| Cediranib studied in …STUDIED_INderived100 of 100show fewer |
|---|
| → studied in | NCT02498613Phase 2 · active not recruiting A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors · 100 trials list this drug (17 active) | — | — | Malignant Breast Neoplasm,Malignant Solid Neoplasm,Lung Non-Small Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03741426Phase 2 · recruiting WIRE - Novel Treatments in Renal Cell Cancer · 100 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02484404Phase 1/Phase 2 · active not recruiting Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can... · 100 trials list this drug (17 active) | — | — | Breast Neoplasm,Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02974621Phase 2 · active not recruiting Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma · 100 trials list this drug (17 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04090567Phase 2 · recruiting Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer · 100 trials list this drug (17 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01364051Phase 1 · active not recruiting Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies · 100 trials list this drug (17 active) | — | — | Malignant Solid Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01064648Phase 1/Phase 2 · active not recruiting Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma · 100 trials list this drug (17 active) | — | — | Malignant Mesothelioma,Pleural Malignant Mesothelioma,Epithelioid Mesothelioma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03660826Phase 2 · active not recruiting Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone · 100 trials list this drug (17 active) | — | — | Carcinosarcoma,Endometrioid Adenocarcinoma,Endometrial Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00750841Phase 1 · active not recruiting Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours · 100 trials list this drug (17 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03851614Phase 2 · active not recruiting Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors · 100 trials list this drug (17 active) | — | — | Leiomyosarcoma,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04739800Phase 2 · active not recruiting Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents · 100 trials list this drug (17 active) | — | — | Low Grade Fallopian Tube Serous Adenocarcinoma,Fallopian Tube Endometrioid Adenocarcinoma,Ovarian Seromucinous Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02345265Phase 2 · active not recruiting Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer · 100 trials list this drug (17 active) | — | — | Primary Peritoneal Carcinoma,Fallopian Tube Endometrioid Adenocarcinoma,Ovarian Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02446600Phase 3 · active not recruiting Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · 100 trials list this drug (17 active) | — | — | Ovarian Endometrioid Tumor,Ovarian Serous Tumor,Primary Peritoneal Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02893917Phase 2 · active not recruiting Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer · 100 trials list this drug (17 active) | — | — | Prostate Adenocarcinoma,Prostate Adenocarcinoma with Neuroendocrine Differentiation,Prostate Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01116648Phase 1/Phase 2 · active not recruiting Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer · 100 trials list this drug (17 active) | — | — | Fallopian Tube Carcinoma,Ovarian Endometrioid Adenocarcinoma,Ovarian Serous Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02502266Phase 2/Phase 3 · active not recruiting Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer · 100 trials list this drug (17 active) | — | — | Primary Peritoneal Carcinoma,Fallopian Tube Endometrioid Adenocarcinoma,Ovarian Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07648745Phase 2 · completed Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian Cancer · 100 trials list this drug (17 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01391962Phase 2 · completed Sunitinib or Cediranib for Alveolar Soft Part Sarcoma · 100 trials list this drug (17 active) | — | — | Alveolar Soft Part Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03334617Phase 2 · active not recruiting Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy · 100 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00942877Phase 2 · completed Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma · 100 trials list this drug (17 active) | — | — | Alveolar Soft Part Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03314740Phase 2 · completed Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib · 100 trials list this drug (17 active) | — | — | Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03117933Phase 2 · completed Olaparib +/- Cediranib or Chemotherapy in Patients With Platinum-resistant Ovarian Cancer · 100 trials list this drug (17 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02899728Phase 2 · terminated Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer · 100 trials list this drug (17 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00795340Phase 3 · completed Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 100 trials list this drug (17 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00107250Phase 1 · completed AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07) · 100 trials list this drug (17 active) | — | — | Adult Solid Neoplasm,Malignant Lung Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00245154Phase 2/Phase 3 · completed Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer · 100 trials list this drug (17 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00343408Phase 1 · completed AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer · 100 trials list this drug (17 active) | — | — | Malignant Lung Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00662506Phase 1/Phase 2 · completed Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma · 100 trials list this drug (17 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01160926Phase 1 · terminated Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY Trial · 100 trials list this drug (17 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03278717Phase 3 · unknown Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients · 100 trials list this drug (17 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01062425Phase 2 · completed Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma · 100 trials list this drug (17 active) | — | — | Adult Glioblastoma,Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02681237NA · completed A Study of Cediranib and Olaparib at Disease Worsening in Ovarian Cancer · 100 trials list this drug (17 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03570437Phase 2 · unknown Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel? · 100 trials list this drug (17 active) | — | — | Carcinosarcoma,Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02855697early Phase 1 · completed Multi-maintenance Olaparib After Disease Recurrence in Participants With Platinum Sensitive BRCAm High Grade Serous Ovarian Cancer · 100 trials list this drug (17 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01208051Phase 1/Phase 2 · completed Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer · 100 trials list this drug (17 active) | — | — | Thyroid Gland Follicular Carcinoma,Thyroid Gland Oncocytic Carcinoma,Differentiated Thyroid Gland Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01065662Phase 1 · completed AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies · 100 trials list this drug (17 active) | — | — | Malignant Peritoneal Neoplasm,Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04184518Phase 2 · withdrawn Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma · 100 trials list this drug (17 active) | — | — | Malignant Neoplasm,Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01132820Phase 2 · completed Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer · 100 trials list this drug (17 active) | — | — | Endometrial Adenocarcinoma,Endometrial Serous Adenocarcinoma,Endometrial Adenosquamous Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01337401Phase 2 · unknown A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS) · 100 trials list this drug (17 active) | — | — | Alveolar Soft Part Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00436956Phase 2 · completed AZD2171 to Treat Prostate Cancer · 100 trials list this drug (17 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00278343Phase 2 · completed Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer · 100 trials list this drug (17 active) | — | — | Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00243061Phase 2 · completed AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma · 100 trials list this drug (17 active) | — | — | Melanoma,Uveal Melanoma,Iris Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00527124Phase 2 · terminated Docetaxel and Prednisone With or Without Cediranib in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy · 100 trials list this drug (17 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01260688Phase 2 · completed Cediranib Maleate With or Without Dasatinib in Patients With HRPC-Resistant to Treatment With Docetaxel · 100 trials list this drug (17 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02340611Phase 2 · completed A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib · 100 trials list this drug (17 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00410904Phase 2 · completed AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer · 100 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00243074Phase 2 · completed S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery · 100 trials list this drug (17 active) | — | — | Malignant Mesothelioma,Pleural Solitary Fibrous Tumor,Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00326872Phase 2 · terminated AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine · 100 trials list this drug (17 active) | — | — | Plexiform Neurofibroma,Spinal Cord Neurofibroma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01310855Phase 2 · terminated Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma · 100 trials list this drug (17 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00384176Phase 2/Phase 3 · completed First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX · 100 trials list this drug (17 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588900Phase 2 · terminated Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab · 100 trials list this drug (17 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01229111Phase 2 · terminated Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers · 100 trials list this drug (17 active) | — | — | Malignant Gallbladder Neoplasm,Malignant Extrahepatic Bile Duct Neoplasm,Adult Cholangiocarcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00326599Phase 2 · completed Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 100 trials list this drug (17 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00475150Phase 2 · completed Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome · 100 trials list this drug (17 active) | — | — | Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00423332Phase 2 · completed Cediranib (AZD2171, RECENTIN™) in Metastatic or Recurrent Renal Cell Carcinoma · 100 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00399035Phase 3 · completed Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer · 100 trials list this drug (17 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00777153Phase 3 · completed Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma · 100 trials list this drug (17 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00427973Phase 2 · terminated AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer · 100 trials list this drug (17 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454805Phase 2 · completed AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer. · 100 trials list this drug (17 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00326664Phase 1 · completed AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors · 100 trials list this drug (17 active) | — | — | Childhood Central Nervous System Germ Cell Tumor,Childhood Atypical Teratoid/Rhabdoid Tumor,Childhood Grade 1 Meningioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00227760Phase 2 · completed Cediranib Maleate in Treating Patients With Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By Surgery · 100 trials list this drug (17 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00244881Phase 2 · completed A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202) · 100 trials list this drug (17 active) | — | — | Malignant Breast Neoplasm,Male Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00275028Phase 2 · completed AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer · 100 trials list this drug (17 active) | — | — | Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma,Primary Peritoneal Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00532194Phase 3 · unknown An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer · 100 trials list this drug (17 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00458978Phase 2 · completed Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer · 100 trials list this drug (17 active) | — | — | Salivary Gland Carcinoma,Laryngeal Squamous Cell Carcinoma,Laryngeal Verrucous Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00979862Phase 1 · completed Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma · 100 trials list this drug (17 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01131234Phase 1 · completed Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors · 100 trials list this drug (17 active) | — | — | Adult Solid Neoplasm,Malignant Breast Neoplasm,Melanoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00939848Phase 2/Phase 3 · completed Cediranib Versus Placebo Plus Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract Cancers · 100 trials list this drug (17 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00245063Phase 2 · completed AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer · 100 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00309946Phase 2 · completed Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery · 100 trials list this drug (17 active) | — | — | Malignant Mesothelioma,Pleural Solitary Fibrous Tumor,Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00621725Phase 1 · completed Phase 1 PK Study of Cediranib in Single and Multiple Doses in Hepatically Impaired Patients With Solid Tumours · 100 trials list this drug (17 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00303862Phase 2 · terminated AZD2171 in Treating Patients With Refractory Metastatic Kidney Cancer · 100 trials list this drug (17 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00494221Phase 1/Phase 2 · completed A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX · 100 trials list this drug (17 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00458731Phase 1 · completed Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma · 100 trials list this drug (17 active) | — | — | Adult Solid Neoplasm,Childhood Solid Neoplasm,Anaplastic Large Cell Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00243347Phase 1 · completed The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer · 100 trials list this drug (17 active) | — | — | Head and Neck Neoplasm,Carcinoma,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01229930Phase 2 · completed Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery · 100 trials list this drug (17 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00305656Phase 2 · completed AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme · 100 trials list this drug (17 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00310089NA · completed AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer · 100 trials list this drug (17 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00238394Phase 2 · completed Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer · 100 trials list this drug (17 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00937482Phase 1 · terminated Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer · 100 trials list this drug (17 active) | — | — | Malignant Breast Neoplasm,Melanoma,Lung Non-Small Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00321724Phase 2 · completed AZD2171 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia · 100 trials list this drug (17 active) | — | — | Chronic Lymphocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00621361Phase 1 · completed Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients · 100 trials list this drug (17 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00306891Phase 2 · completed Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™) · 100 trials list this drug (17 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00278889Phase 2 · completed Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX) · 100 trials list this drug (17 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00264004Phase 2 · completed Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours · 100 trials list this drug (17 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00385203Phase 2 · completed The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST). · 100 trials list this drug (17 active) | — | — | Gastrointestinal Stromal Tumor,Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00502567Phase 1 · completed A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors · 100 trials list this drug (17 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00748891Phase 1 · completed DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study) · 100 trials list this drug (17 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00981721Phase 1 · completed A Study to Determine the Pharmacokinetics of Cediranib in Chinese Patients With Advanced Solid Malignancies · 100 trials list this drug (17 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00960349Phase 1 · completed Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients · 100 trials list this drug (17 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00539331Phase 1 · terminated Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients · 100 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00750425Phase 1 · completed Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours · 100 trials list this drug (17 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00501605Phase 1 · completed Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases · 100 trials list this drug (17 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00502164Phase 1 · completed Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer · 100 trials list this drug (17 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00502385Phase 1 · completed Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML · 100 trials list this drug (17 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00475956Phase 1 · completed Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours · 100 trials list this drug (17 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00503204Phase 1 · completed Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour · 100 trials list this drug (17 active) | — | — | Glioblastoma,Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00503477Phase 1 · completed A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 in Solid Tumors in Japan · 100 trials list this drug (17 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00502060Phase 1 · completed Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced Cancer · 100 trials list this drug (17 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00503412Phase 1 · completed Phase I Orally Administered 14C-AZD2171 in Patients With Solid Metastatic Tumors · 100 trials list this drug (17 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |